Price range: $150.00 through $500.00
⚠️ Important Notice:
This product is sold strictly for laboratory research purposes only. It is not for human or animal use, and not for therapeutic or diagnostic applications.
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations.
Sold in a single 3 mL vial filled crystalized powder and will need to be reconstituted with Bacteriostatic water for use.
Retatrutide (also known as LY3437943) is an investigational, once-weekly injectable that activates three incretin-related receptors at once: GIP, GLP-1, and glucagon (GCG). It is not FDA-approved (research/clinical-trial status). In phase-2 studies, adults with obesity showed large, dose-dependent weight reductions over 24–48 weeks, with a safety profile generally similar to other GLP-1–based medicines.
| Size | 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60mg |
|---|
© 2026 Auctus Pharma. All Rights Reserved.
There are no reviews yet.